Vaccine rollout faces dilemma over who gets what as coalition tries to reach its key targets
Delivery schedules and vaccine restrictions make it highly likely HSE will have to administer over 400,000 vaccines a week by June
The vaccine rollout is facing a host of new operational challenges due to vaccine restrictions and delivery schedules, just as it needs to ramp up to hit long-promised targets.
Last week, the National Immunisation Advisory Committee (Niac) advised restricting Johnson & Johnson to the over-50s, while AstraZeneca, which had previously been restricted to the over-60s, will now be allowed for the over-50s as well.
On the face of it, these changes are...
Subscribe from just €1 for the first month!
With any subscription you will have access to
Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine
Vaccine age restrictions create a ‘two-tier’ rollout, says immunologist
Professor Kingston Mills has warned that the new rules mean higher risk groups are getting less effective vaccines
New vaccine deals to deliver 20 million doses by end of 2023
HSE scrambles to reorganise ongoing rollout amid disruption to over-50s plan while IBM and Salesforce are hired to develop vaccine passport app to restart travel sector
Tony O’Brien: High-speed reopening gives no time to evaluate its impact
The government’s reopening plan comes with the knowledge that the vaccine programme here needs to be substantially completed if its gains are to mean anything
Covid-19: Here comes the sun as rollout raises hopes of a brighter future
Society is no longer in suspended animation. But joy at a staged return to normal life is tempered by apprehension on the part of many